Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of CDKN1A
Abstract Background Hypericin-mediated photodynamic therapy (HY-PDT) has recently captured increased attention as an alternative minimally invasive anticancer treatment, although cancer cells may acquire resistance.Therefore, combination treatments may be necessary to enhance HY-PDT efficacy.Histone deacetylase inhibitors (HDACis) are often used in